Simvastatin as an add-on Treatment to Copaxone for the Treatment of Relapsing Multiple Sclerosis
Status:
Withdrawn
Trial end date:
2011-03-01
Target enrollment:
Participant gender:
Summary
A Double Blind, Randomised, Placebo Controlled Study Investigating Simvastatin as an add-on
Treatment to Copaxone for the Treatment of Relapsing Multiple Sclerosis in patients treated
with Copaxone for at least 3 months